Advanz Agrees Multi-Market Omalizumab Deal With Alvotech

Gains Rights To Market Xolair Biosimilar In Europe, Canada And Australiasia

 
• By David Wallace
Blue lungs with world map
Advanz has gained international rights to the asthma treatment • Source: Shutterstock

More from Deals

More from Business